Cancer BiologybioRxivPreprint
PARP inhibitor counteracts Temozolomide Resistance in Glioblastoma Multiforme
Édouard Samarut, Gaston Tabourel, Joséphine Briand…·Aurélien A. Sérandour
This paper shows that combining temozolomide with the PARP inhibitor olaparib overcomes TMZ resistance in glioblastoma by restoring sensitivity in MMR-deficient and MGMT-expressing cells.
DOI 10.1101/2024.12.13.627927